Homepage
Author:
Currax Pharmaceuticals LLC
Posted Date:
April 9, 2026
New Peer-Reviewed Scientific Publication Establishes Rationale for Combination Pharmacotherapy in Achieving Durable Weight Management
Currax Pharmaceuticals LLC
April 9, 2026
Currax Expands Patient Access to FDA-Approved Obesity Treatment with PeekDirectâ˘
Currax Pharmaceuticals LLC
April 1, 2026
CONTRAVE Given the Highest Recommendation by Joint TOS/OMA/OAC Expert Guidance Statement on the Pharmacological Management of United States Adults with Overweight or Obesity
Currax Pharmaceuticals LLC
March 25, 2026
